ANI Pharma Inc (28) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Asset Purchase Agreement between Holmdel Pharmaceuticals, LP and ANI Pharmaceuticals, Inc
(Filed With SEC on May 10, 2022)
-
Underwriting Agreement, dated November 3, 2021, between ANI Pharmaceuticals, Inc. and Guggenheim Securities, LLC
(Filed With SEC on November 4, 2021)
-
Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership
(Filed With SEC on March 9, 2021)
-
Inducement Stock Option Award Agreement, effective as of September 8, 2020, between ANI Pharmaceuticals, Inc. and Nikhil Lalwani
(Filed With SEC on November 5, 2020)
-
Asset Purchase Agreement between Cranford Pharmaceuticals, LLC and ANI Pharmaceuticals, Inc
(Filed With SEC on May 10, 2022)
-
Asset Purchase Agreement between Amerigen Pharmaceuticals LTD. and ANI Pharmaceuticals, Inc
(Filed With SEC on February 27, 2020)
-
Form of Restricted Stock Grant Agreement
(Filed With SEC on February 27, 2020)
-
Form of Non- Statutory Stock Option Agreement
(Filed With SEC on February 27, 2020)
-
Amendment No. 4 to Asset Purchase Agreement between ANI Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc
(Filed With SEC on May 9, 2019)